DLL3 CAR mRNA-LNP

Cat. No.: TDLD-0825-LD41

DLL3 CAR mRNA-LNP

DLL3 CAR mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the Chimeric Antigen Receptor (CAR) targeting Delta-like ligand 3 (DLL3), serving as an excellent tool for investigating CAR-T cell therapy against DLL3-expressing solid tumors and studying receptor-specific immune modulation. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of DLL3 CAR mRNA-LNP include monitoring CAR expression on transduced T cells and evaluating CAR-T cell functionality against DLL3-positive targets. Please note that this product is intended for research purposes only.